Avid Bioservices Inc (CDMO)

[Protector]

hayward, in all that one also has to keep in mind that the clock doesn't start ticking at end of enrolment, say DEC 2015 till end of trial, say DEC 2016.

Many patients have been enrolled since JAN 2014, with a bulk increase (hockey stick) as of JUN 2014. So those patients will have been 2 to 3 years (24 to 36 months) in the trial at unblinding in DEC 2016.

But actually also not so much less in H2/2016 for the second look-in.

Docetaxel alone is 9.9 months for the ECOG groups in SUNRISE. So in OCT 2014 the curve could have started to separate if Bavi does well.